Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management (as Zepbound)
Ahmad S et al
The translational machinery of human CD4(+) T cells is poised for activation and controls the switch from quiescence to metabolic remodeling
Patients following vegetarian or vegan diets may need additional B12 supplementation, as this vitamin is primarily found in animal products
3, the Danish drugmaker will present more extensive data from its two large Phase 3 trials of semaglutide, involving 3,808 total participants
This recognition encouraged preclinical studies aiming to investigate both mechanistic aspects and intervention strategies to characterize and target this biological axis in conditions affecting muscle, brain, the immune system, and metabolic diseases